- 专利标题： HYALURONIC ACID-CONJUGATED DIPALMITOYL PHOSPHATIDYL ETHANOLAMINE IN COMBINATION WITH NON-STEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS) FOR TREATING OR ALLEVIATING INFLAMMATORY DISEASES
-
申请号： US18549042申请日： 2022-03-13
-
公开(公告)号： US20240165148A1公开(公告)日： 2024-05-23
- 发明人: Saul YEDGAR
- 申请人： Saul YEDGAR
- 申请人地址： IL Jerusalem
- 专利权人： Saul YEDGAR
- 当前专利权人： Saul YEDGAR
- 当前专利权人地址： IL Jerusalem
- 国际申请： PCT/IL2022/050282 2022.03.13
- 进入国家日期： 2023-09-05
- 主分类号： A61K31/728
- IPC分类号： A61K31/728 ; A61K31/365 ; A61K31/415 ; A61K31/612 ; A61K47/24 ; A61P29/00
摘要：
The present invention relates to combination therapies and compositions comprising a lipid conjugate composed of dipalmitoyl- phosphatidyl-ethanol-amine (DPPE) and Hyaluronic Acid (Hy) in combination with a non-steroidal anti-inflammatory drug (NSAID), and uses of same in treating inflammatory and/or allergic diseases or conditions.
信息查询
IPC分类:
